Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHARE-D: Endotoxin Challenge in Older Adults with Insomnia
NCT03256760Phase 1Completed
- Start
- Aug 2017
- Primary completion
- Apr 2024
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lipopolysaccharide endotoxin in major depressive disorder (MDD). Primary endpoints: Depressed Mood Subscale of the Profile of Mood States at 12 hours and Montgomery Asberg Depression Rating Scale at 8 hours. Started Aug 2017; status: completed.
02
Drugs
lipopolysaccharide endotoxin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03256760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256760.